Antimicrobial 1,3,4-trisubstituted-1,2,3-triazolium salts

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Antimicrobial Research

Background:

• The rise of antimicrobial resistance necessitates the development of novel therapeutic agents.
• Triazole and triazolium compounds are recognized for their diverse biological activities.

Purpose of the Study:

• To synthesize novel 1,3,4-trisubstituted-1,2,3-triazolium bromide salts.
• To evaluate the antimicrobial potential of these salts and their neutral triazole precursors.

Main Methods:

• Synthesis via a two-step sequence: azide-alkyne cycloaddition followed by benzylic substitution.
• Antimicrobial activity assessment using minimum inhibitory concentration (MIC) assays against Gram-positive bacteria, Gram-negative bacteria, and fungi.

Main Results:

• Triazolium bromide salts exhibited significant antimicrobial activity, with MIC values as low as 1 µM against Gram-positive bacteria, 8 µM against Gram-negative bacteria, and 4 µM against fungi.
• Neutral triazole precursors showed no significant antimicrobial activity.
• Structure-activity relationship analysis indicated that cationic charge and hydrophobicity balance are critical for activity, while substituent identity and regiochemistry have minimal impact.

Conclusions:

• 1,3,4-trisubstituted-1,2,3-triazolium bromide salts represent a promising class of antimicrobial agents.
• The cationic nature and optimized hydrophobicity of these compounds are key drivers of their potent and broad-spectrum antimicrobial effects.
• Further development of triazolium-based compounds could lead to new treatments for microbial infections.